Ras inhibitors
US12202845B2 · kind B2 · utility
2Cited by
27References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 7, 2022 |
| Grant date | Jan 21, 2025 |
| Priority date | — |
| Expiry date | Oct 7, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features macrocyclic compounds, and pharmaceutical compositions and protein complexes thereof, capable of inhibiting Ras proteins, and their uses in the treatment of cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.